Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.71 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.59 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.59 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KDR | P35968 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | TNF | P01375 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29740060 | 1.00 | CSNK2A1 (1.00) | CSNK2A1MCL1CA1CA2PTGS2 | |
| Ammonia Solution, Strong SCHEMBL25338596 | 0.98 | CSNK2A1 (0.96) | CSNK2A1MCL1CA1CA2PTGS2 | |
| Ethane SCHEMBL27837259 | 0.98 | CSNK2A1 (0.96) | CSNK2A1MCL1CA1CA2PTGS2 | |
| SCHEMBL18741295 | 0.98 | CSNK2A1 (0.96) | CSNK2A1MCL1CA1CA2PTGS2 | |
| SCHEMBL18741297 | 0.98 | CSNK2A1 (0.96) | CSNK2A1MCL1CA1CA2PTGS2 | |
| Bromide SCHEMBL10876570 | 0.98 | CSNK2A1 (0.96) | CSNK2A1MCL1CA1CA2PTGS2 | |
| Hydrochloric Acid SCHEMBL10875048 | 0.98 | CSNK2A1 (0.96) | CSNK2A1MCL1CA1CA2PTGS2 | |
| Formaldehyde SCHEMBL11413714 | 0.96 | CSNK2A1 (0.92) | CSNK2A1MCL1CA1CA2PTGS2 | |
| SCHEMBL4292219 | 0.92 | CSNK2A1 (0.85) | CSNK2A1MCL1CA1CA2PTGS2 | |
| SCHEMBL9769750 | 0.86 | CSNK2A1 (0.73) | CSNK2A1MCL1CA1CA2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011393-A | Vinyl silicone oil and preparation method thereof | 江西科睿新材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260092029-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | SCRIPPS RESEARCH INST (US) | 2026-04-02 | — | — | US | claimed |
| EP-4584236-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | The Scripps Research Institute (US) | 2025-07-16 | — | — | EP | claimed |
| CN-118880486-B | Cool polyester fiber and preparation method thereof | 江苏恒科新材料有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120058780-A | Preparation method and application of tricyclohexyltin-5-methyl salicylate complex | 衡阳师范学院 | 2025-05-30 | — | — | CN | claimed |
| CN-119841858-A | Preparation method and application of tris (2-methyl-2-phenylpropyl) tin-5-methyl salicylate complex | 衡阳师范学院 | 2025-04-18 | — | — | CN | claimed |
| CN-119823825-A | Myrtle essential oil and application of compound essential oil based on myrtle essential oil in pest control | 广东海洋大学 | 2025-04-15 | — | — | CN | claimed |
| CN-119465669-A | Dyeing liquid for optical resin, dyed optical resin, and preparation method and application of dyed optical resin | 拓烯科技(衢州)有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119194880-A | Dyeing assistant composition for optical resin dyeing, dyeing method of optical resin and dyed optical resin | 拓烯科技(衢州)有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119144349-A | Density regulation and control method of surfactant liquid-liquid coacervation phase system and application thereof | 中国科学技术大学苏州高等研究院 | 2024-12-17 | — | — | CN | claimed |
| EP-0036145-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1985-05-29 | — | — | EP | claimed |
| EP-0031561-B1 | A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT | MERCK & CO. INC. (US) | 1985-04-10 | — | — | EP | claimed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | claimed |
| US-4464363-A | HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS | MERCK & CO., INC. (US) | 1984-08-07 | — | — | US | claimed |
| US-4459295-A | Method of increasing oral absorption of glycosidic and related antibiotics | INTERX RESEARCH CORPORATION (US) | 1984-07-10 | — | — | US | claimed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092029-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | CYP2B6, CYP2A6, CYP1A1 | CSNK2A1 2191/4885MCL1 1176/4885CA1 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.